Drug-induced eosinophilic pneumonia in a patient with Crohn's disease: diagnosis and treatment using fraction of exhaled nitric oxide
Intestinal Research
;
: 529-534, 2017.
Artículo
en Inglés
| WPRIM
| ID: wpr-220093
ABSTRACT
Oral 5-aminosalicylic acid agents (mesalazine and sulfasalazine) and azathioprine are the mainstays of treatment for inflammatory bowel disease. Reports of pulmonary toxicity induced by oral 5-aminosalicylic acid agents or azathioprine in patients with inflammatory bowel disease are very rare; to date, only 38 cases have been reported worldwide. We, herein, report a case involving a 26-year-old man who was diagnosed with eosinophilic pneumonia after using mesalazine and azathioprine for the treatment of Crohn's disease and recovered after treatment. We also found that the fraction of exhaled nitric oxide level was elevated in this patient. After treatment, the fraction of exhaled nitric oxide level decreased and the symptoms improved. The present case shows that fraction of exhaled nitric oxide is related to the disease activity and treatment effectiveness of druginduced eosinophilic pneumonia.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Eosinofilia Pulmonar
/
Azatioprina
/
Enfermedades Inflamatorias del Intestino
/
Enfermedad de Crohn
/
Resultado del Tratamiento
/
Mesalamina
/
Diagnóstico
/
Eosinófilos
/
Óxido Nítrico
Tipo de estudio:
Estudio diagnóstico
Límite:
Adulto
/
Humanos
Idioma:
Inglés
Revista:
Intestinal Research
Año:
2017
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS